Saturday, 12 September 2026

Indian corporate news, decoded into deal flow

NSE LIVE
NIFTY 50 INDIA VIX
as of
MARKETS
DEAL FLOW
GPT Infraprojects Bags ₹85.53 Crore Railway… ▲ Order Book BRICS New Delhi Declaration 2026: Trade,… ▲ Market News / Economy BRICS New Delhi Declaration Flags Unilateral… ▲ Market News / Economy SEBI Opens Consultation on Closing Auction… ▲ Market News / Economy RBI Announces ₹1 Lakh Crore OMO… ▲ Market News / Economy Inflation-Proof Sectors in India: Which Stocks… ▲ Stock Market Learning Aurobindo Pharma Sets Up 100% U.S.… ▲ Mergers & Acquisitions
Home / Order Book / Panacea Biotec Lands ₹127 Crore bOPV Order:Contextualizing Recent Mega Contracts in India’s Industrials
OB · Order Book

Panacea Biotec Lands ₹127 Crore bOPV Order:Contextualizing Recent Mega Contracts in India’s Industrials

Panacea Biotec Lands ₹127 Crore bOPV Order:Contextualizing Recent Mega Contracts in India’s Industrials

Panacea Biotec Limited: bOPV Vaccine Supply Order

Panacea Biotec has secured a domestic contract for the supply of the bivalent oral polio vaccine (bOPV). The key details are as follows:

  • Order Value: ₹127.20 crore

  • Execution Timeline: The supply is to be delivered in tranches over 90 to 480 days following the Letter of Acceptance (LOA) issued on October 8, 2025

  • Contracting Authority: The order has been awarded by the Central Medical Services Society (CMSS), under the Ministry of Health & Family Welfare, Government of India